BioCardia, Inc. (BCDA)

BioCardia Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0.47	0.48	1.35	1.02	0.15	0.71
Revenue Growth (YoY)	-65.49%	-64.72%	33.20%	600.00%	-79.58%	13.60%
Cost of Revenue	0	0	0	0	0	0.36
Gross Profit	0.47	0.48	1.35	1.02	0.14	0.35
Selling, General & Admin	4.29	4.4	4.42	5.09	5.86	6
Research & Development	6.58	7.73	8.83	8.56	9.81	8.56
Operating Expenses	10.88	12.12	13.25	13.65	15.67	14.57
Operating Income	-10.41	-11.64	-11.9	-12.63	-15.53	-14.21
Interest Expense / Income	0	0	0	0	0	0.11
Other Expense / Income	-0.07	-0.07	0.01	-0.01	-0.53	0.38
Pretax Income	-10.34	-11.57	-11.91	-12.62	-15	-14.71
Net Income	-10.34	-11.57	-11.91	-12.62	-15	-14.71
Shares Outstanding (Basic)	2	1	1	1	1	0
Shares Outstanding (Diluted)	2	1	1	1	1	0
Shares Change	24.56%	19.52%	4.75%	67.19%	79.27%	32.37%
EPS (Basic)	-7.05	-8.25	-10.05	-11.25	-22.20	-39.15
EPS (Diluted)	-7.05	-8.25	-10.05	-11.25	-22.20	-39.15
Free Cash Flow	-8.95	-9.99	-10.63	-10.48	-12.39	-9.59
Free Cash Flow Per Share	-5.34	-7.07	-9.00	-9.29	-18.37	-25.49
Gross Margin	100.00%	100.00%	100.00%	100.00%	97.24%	49.58%
Operating Margin	-2224.15%	-2441.09%	-880.25%	-1244.33%	-10709.66%	-2001.83%
Profit Margin	-2208.76%	-2425.79%	-880.70%	-1243.65%	-10347.59%	-2071.69%
Free Cash Flow Margin	-1911.54%	-2093.50%	-786.32%	-1032.71%	-8544.14%	-1350.85%
EBITDA	-9.92	-11.16	-11.53	-11.98	-14.93	-14.05
EBITDA Margin	-2119.87%	-2339.62%	-852.81%	-1180.59%	-10298.62%	-1978.31%
Depreciation & Amortization	0.42	0.41	0.38	0.64	0.07	0.55
EBIT	-10.34	-11.57	-11.91	-12.62	-15	-14.6
EBIT Margin	-2208.76%	-2425.79%	-880.70%	-1243.65%	-10345.52%	-2055.92%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).